年轻低复杂冠心病患者血运重建策略与长期健康结局的加权分析
研究回顾性纳入60岁及以下、冠脉解剖适合CABG和PCI且SYNTAX评分≤22的患者,采用逆概率治疗加权比较PCI(n=374)与CABG(n=173)的长期结局。加权后CABG全因死亡风险显著低于PCI(HR 0.40,95%CI 0.19-0.7),但30天死亡/卒中风险更高。
要点
- 年轻低复杂冠心病患者中,CABG较PCI与更低的长期全因死亡风险相关。
- CABG组30天死亡/卒中风险高于PCI(0.3% vs 1.7%,RR=5.84)。
- 需专门随机试验及更长随访以指导终身治疗选择。
核心结论
- 在适合PCI和CABG的年轻低复杂冠心病患者中,CABG较PCI与更有利的长期健康结局相关。
- 观察结果支持开展专门随机试验并延长随访以更好指导终身治疗选择。
研究设计与样本
- 采用逆概率治疗加权生成特征均衡的伪人群,估计PCI(n=374)与CABG(n=173)的平均治疗效应。
主要发现
- 平均年龄53±7岁,27%患糖尿病,48%表现为急性冠脉综合征,平均SYNTAX评分13.6±4.9,68%以PCI作为指数血运重建策略。
- 加权人群中,CABG vs PCI全因死亡校正风险比0.40(95%CI 0.19-0.7),发生率5.8 vs 14.0死亡/1000人年(中位随访9.3年,IQR 6.9-11.7)。
- 以死亡为竞争风险,CABG组新发血运重建累积风险(亚分布风险比0.72,95%CI 0.32-1.25)和任何原因再入院(亚分布风险比0.70,95%CI 0.41-1.07)低于PCI。
- 30天死亡/卒中率CABG高于PCI(0.3% vs 1.7%;风险比=5.84)。
临床怎么用
- 对60岁及以下、SYNTAX评分≤22且适合两种血运重建方式的冠心病患者,CABG可作为优先考虑以改善长期生存。
- 决策时需权衡CABG较高的30天死亡/卒中风险与长期生存获益。
局限性
- 为回顾性准实验分析,非随机对照,可能存在未测量混杂。
- 样本量有限(PCI n=374,CABG n=173),部分结局置信区间较宽。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Age is an important factor weighing on revascularization decisions. We analysed long-term health outcomes of young patients with low-complexity coronary anatomy suitable for both coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), according to revascularization strategy. METHODS: Patients 60 years old or less, undergoing invasive coronary angiography between January 2007 and December 2015, presenting with proximal left anterior descending artery involvement, left main or multivessel disease and a SYNTAX Score ≤22 were retrospectively selected. An inverse probability of treatment weight methodology generated a pseudopopulation with well-balanced characteristics, which was used to estimate the average treatment effect between PCI (n = 374) and CABG (n = 173). RESULTS: Mean age was 53 ± 7 years old, 27% had diabetes mellitus and 48% presented with an acute coronary syndrome. Mean SYNTAX score was 13.6 ± 4.9 and 68% underwent PCI as index revascularization strategy. In the weighed population, the adjusted hazard of the primary end-point of all-cause death at total follow-up (median 9.3 years; interquartile range 6.9-11.7) was 0.40 (95% confidence interval 0.19-0.7) for CABG vs PCI (incidence rate 5.8 vs 14.0 deaths/1000-person-years). Accounting for death as competing risk, the cumulative hazard of new revascularization (sub-distribution hazard ratio 0.72; 95% confidence interval 0.32-1.25) and any cause hospital readmission (sub-distribution hazard ratio 0.70; 95% confidence interval 0.41-1.07) were lower in CABG patients, as opposed to death/stroke rates at 30 days which were higher with CABG (0.3% vs 1.7%; risk ratio = 5.84). CONCLUSIONS: In this quasi-experimental analysis of young patients with coronary artery disease and an equivalent indication for both PCI and CABG, long-term health outcomes were favourably associated with CABG, as compared to PCI. These observations support the need for dedicated randomized trials with longer follow-up in order to better inform lifetime treatment options.
引用
- Custódio P, Garcez L, Madeira S, et al. Long-term health outcomes of young patients with low-complexity coronary disease: a weighted analysis according to revascularization strategy. Eur J Cardiothorac Surg. 2024. PMID: 39374540. doi:10.1093/ejcts/ezae367
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。